Literature DB >> 6426465

Cystatin-like cysteine proteinase inhibitors from human liver.

G D Green, A A Kembhavi, M E Davies, A J Barrett.   

Abstract

Cysteine proteinase inhibitor (CPI) forms from human liver were purified from the tissue homogenate by alkaline denaturation of cysteine proteinases with which they are complexed, acetone fractionation, affinity chromatography on S-carboxymethyl-papain-Sepharose and chromatofocusing. The multiple forms of CPI were shown immunologically to be forms of two proteins, referred to as CPI-A (comprising the forms of relatively acidic pI) and CPI-B (comprising the more basic forms). CPI-A and CPI-B are similar in their Mr of about 12400, considerable stability to pH2, pH11 and 80 degrees C, and tight-binding inhibition of papain, several related cysteine proteinases and dipeptidyl peptidase I. Ki values were determined for papain, human cathepsins B, H and L, and dipeptidyl peptidase I. The affinity of CPI-A for cathepsin B was about 10-fold greater than that of CPI-B, whereas CBI-B showed about 100-fold stronger inhibition of dipeptidyl peptidase I. For all the cysteine proteinases the liver inhibitors were somewhat less tight binding than cystatin. The resemblance of both CPI-A and CPI-B in several respects to egg-white cystatin is discussed. CPI-A seems to correspond to the epithelial inhibitor described previously, and CPI-B to the inhibitor from other cell types [Järvinen & Rinne (1982) Biochim. Biophys. Acta 708, 210-217].

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6426465      PMCID: PMC1153426          DOI: 10.1042/bj2180939

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  FURTHER PURIFICATION OF A PROTEASE INHIBITOR FROM RABBIT SKIN WITH HEALING INFLAMMATION.

Authors:  K UDAKA; H HAYASHI
Journal:  Biochim Biophys Acta       Date:  1965-02-15

2.  Isolation and characterization of papaya peptidase A from commercial chymopapain.

Authors:  G W Robinson
Journal:  Biochemistry       Date:  1975-08-12       Impact factor: 3.162

3.  Thermostable endogenous inhibitors of cathepsins B and H.

Authors:  J F Lenney; J R Tolan; W J Sugai; A G Lee
Journal:  Eur J Biochem       Date:  1979-11-01

4.  The low-molecular-weight SH-protease inhibitor in rat skin is epidermal.

Authors:  M Järvinen; O Räsänen; A Rinne
Journal:  J Invest Dermatol       Date:  1978-08       Impact factor: 8.551

5.  Proteinase inhibitors of bovine nasal cartilage.

Authors:  P J Roughley; G Murphy; A J Barrett
Journal:  Biochem J       Date:  1978-03-01       Impact factor: 3.857

6.  In vitro and in vivo inhibition of rat liver cathepsin L by epidermal proteinase inhibitor.

Authors:  T Hibino; K Fukuyama; W L Epstein
Journal:  Biochem Biophys Res Commun       Date:  1980-03-28       Impact factor: 3.575

7.  Chicken alpha2-proteinase inhibitor: a serum protein homologous with ovoinhibitor of egg white.

Authors:  A J Barrett
Journal:  Biochim Biophys Acta       Date:  1974-11-05

8.  A necessary modification to the preparation of papain from any high-quality latex of Carica papaya and evidence for the structural integrity of the enzyme produced by traditional methods.

Authors:  B S Baines; K Brocklehurst
Journal:  Biochem J       Date:  1979-02-01       Impact factor: 3.857

9.  Purification and some characteristics of the human epidermal SH-protease inhibitor.

Authors:  M Järvinen
Journal:  J Invest Dermatol       Date:  1978-08       Impact factor: 8.551

10.  Cathepsin D. Purification of isoenzymes from human and chicken liver.

Authors:  A J Barrett
Journal:  Biochem J       Date:  1970-04       Impact factor: 3.857

View more
  23 in total

Review 1.  Evolutionary families of peptidase inhibitors.

Authors:  Neil D Rawlings; Dominic P Tolle; Alan J Barrett
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

2.  Skeletal muscle and liver contain a soluble ATP + ubiquitin-dependent proteolytic system.

Authors:  J M Fagan; L Waxman; A L Goldberg
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

3.  Inhibition of chicken calpain II by proteins of the cystatin superfamily and alpha 2-macroglobulin.

Authors:  C Crawford
Journal:  Biochem J       Date:  1987-12-01       Impact factor: 3.857

4.  Cystatins from bovine brain: purification, some properties, and action on substance P degrading activity.

Authors:  H G Aghajanyan; A M Arzumanyan; A A Arutunyan; T N Akopyan
Journal:  Neurochem Res       Date:  1988-08       Impact factor: 3.996

5.  Degradation of laminin by human tumor cathepsin B.

Authors:  T T Lah; M R Buck; K V Honn; J D Crissman; N C Rao; L A Liotta; B F Sloane
Journal:  Clin Exp Metastasis       Date:  1989 Jul-Aug       Impact factor: 5.150

6.  Immunolocalization of human cystatins in neutrophils and lymphocytes.

Authors:  M E Davies; A J Barrett
Journal:  Histochemistry       Date:  1984

7.  Inhibition of cysteine proteinases and dipeptidyl peptidase I by egg-white cystatin.

Authors:  M J Nicklin; A J Barrett
Journal:  Biochem J       Date:  1984-10-01       Impact factor: 3.857

8.  Human liver cathepsin L.

Authors:  R W Mason; G D Green; A J Barrett
Journal:  Biochem J       Date:  1985-02-15       Impact factor: 3.857

9.  Structure-function studies of an engineered scaffold protein derived from stefin A. I: Development of the SQM variant.

Authors:  Toni Hoffmann; Lukas Kurt Josef Stadler; Michael Busby; Qifeng Song; Anthony T Buxton; Simon D Wagner; Jason J Davis; Paul Ko Ferrigno
Journal:  Protein Eng Des Sel       Date:  2010-02-23       Impact factor: 1.650

Review 10.  Molecular background of progressive myoclonus epilepsy.

Authors:  Anna-Elina Lehesjoki
Journal:  EMBO J       Date:  2003-07-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.